PMEF
OPTN

Point72 Middle East FZE’s OptiNose OPTN Stock Holding History

Point72 Middle East FZE’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-848
Closed -$24.6K – 1927
2023
Q1 		$24.6K Buy
+848
New +$22.6K ﹤0.01% 1390

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Point72 Middle East FZE's OPTN Position: Q2 2023 in Review

Point72 Middle East FZE sold out of OptiNose (OPTN) in Q2 2023, closing a stake of 848 shares — an estimated $24.6K sold.

Point72 Middle East FZE first reported a position in OPTN in Q1 2023 and held it in 1 quarter. The position peaked at $24.6K in Q1 2023. 61 funds tracked by Wall St. Rank hold OPTN as of Q2 2023.

  • Point72 Middle East FZE reported no remaining OptiNose position as of Q2 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 848 OptiNose shares in Q2 2023, an estimated $24.6K.
  • Point72 Middle East FZE first reported a position in OptiNose in Q1 2023 and held it in 1 quarter.
  • Point72 Middle East FZE's OptiNose position peaked at $24.6K in Q1 2023.
  • 61 funds tracked by Wall St. Rank held OptiNose as of Q2 2023.

Based on Point72 Middle East FZE's 13F filing for Q2 2023, filed 14 Aug 2023.